Springworks Therapeutics (SWTX)
NASDAQ:SWTX
US Market
Holding SWTX?
Track your performance easily

Springworks Therapeutics (SWTX) Financial Statements

330 Followers

Springworks Therapeutics Financial Overview

Springworks Therapeutics's market cap is currently ―. The company's EPS TTM is $-4.277; its P/E ratio is -7.55; Springworks Therapeutics is scheduled to report earnings on October 31, 2024, and the estimated EPS forecast is $-0.75. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 59.73M$ 21.01M$ 5.45M--
Gross Profit$ 57.28M$ 19.80M$ 5.03M--
EBIT$ -39.92M$ -87.39M-$ -79.44M$ -77.92M
EBITDA$ -39.08M$ -86.66M--$ -77.54M
Net Income Common Stockholders$ -39.92M$ -87.39M$ -94.32M$ -79.44M$ -77.92M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 383.88M$ 436.58M$ 479.25M$ 422.42M$ 476.71M
Total Assets$ 617.33M$ 656.83M$ 725.79M$ 467.65M$ 517.33M
Total Debt$ 7.06M$ 6.56M$ 7.06M$ 7.33M$ 7.61M
Net Debt$ -376.83M$ -430.02M$ -472.19M$ -415.09M$ -469.10M
Total Liabilities$ 60.60M$ 89.39M$ 99.57M$ 72.75M$ 65.89M
Stockholders Equity$ 579.07M$ 567.44M$ 626.22M$ 394.90M$ 451.42M
Cash Flow-
Free Cash Flow$ -54.02M$ -79.51M--$ -50.90M
Operating Cash Flow$ -41.79M$ -78.93M$ -62.70M$ -50.46M$ -47.81M
Investing Cash Flow$ 289.00K$ 21.46M$ -159.21M$ 34.60M$ 60.76M
Financing Cash Flow$ 3.37M$ -552.00K$ 299.07M$ -242.00K$ -342.00K
Currency in USD

Springworks Therapeutics Earnings and Revenue History

Springworks Therapeutics Debt to Assets

Springworks Therapeutics Cash Flow

Springworks Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis